XBI Average Annual Return 10 Years
Growth of $10,000.00
With Dividends Reinvested Into XBI


Also see:
XBI stock yearly return 2012
XBI stock yearly return 2013
XBI stock yearly return 2014
XBI stock yearly return 2015
XBI stock yearly return 2016
XBI stock yearly return 2017
XBI stock yearly return 2018
XBI stock yearly return 2019
XBI stock yearly return 2020
XBI stock yearly return 2021
XBI YTD return
Compare XBI average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 10/01/2012
End date: 09/28/2022
Start price/share: $31.24
End price/share: $81.20
Starting shares: 320.10
Ending shares: 330.54
Dividends reinvested/share: $2.12
Total return: 168.40%
XBI Average Annual Return: 10.38%
Starting investment: $10,000.00
Ending investment: $26,840.24


XBI average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
SPDR S&P Biotech is an open-end investment management company. The Fund seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. As of June 30 2015, the Fund's total assets and investment porfolio totaled $3,360,344,396 and $3,327,690,681, respectively. The XBI average annual return 10 years is shown above.

The Average Annual Return on the XBI average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether XBI average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the XBI average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree XBI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
SPDR Series Trust - S and P Biotech ETF (XBI) is categorized under the Financials sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

XES Average Annual Return
XFLT Average Annual Return
XHB Average Annual Return
XHE Average Annual Return
XHR Average Annual Return
XHS Average Annual Return
XIN Average Annual Return
XLB Average Annual Return
XLE Average Annual Return
XLF Average Annual Return
More Financials companies »

★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, SPDR Series Trust - S and P Biotech ETF (XBI) ranks within the highest 50% of all stocks whose returns we have reviewed.
What has the average annual return been for XBI over the past ten years?
✔️Accepted answer: The ten year XBI average annual return has been 10.38% with dividends reinvested.

When you say 'with dividends reinvested' what does that mean?
✔️Accepted answer: That means that each time the stock goes ex-dividend, the average annual return calculation then factors in how that dividend amount could have been reinvested into more shares of XBI at the then-current price — often this is referred to as 'compounding' and is very important when considering average annual return over a long period like a full decade.

What start date was used in your XBI average annual return calculation?
✔️Accepted answer: The start date was 10/01/2012.

What end date was used in your XBI average annual return calculation?
✔️Accepted answer: The end date was 09/28/2022.

If I had invested $10,000 into XBI ten years ago, how much would I have today?
✔️Accepted answer: With dividends reinvested, as of 09/28/2022, you would have $26,840.24.

What does that work out to on a total return basis?
✔️Accepted answer: The XBI ten year total return ending 09/28/2022 works out to 168.40%.


Also see:
XBI stock yearly return 2012
XBI stock yearly return 2013
XBI stock yearly return 2014
XBI stock yearly return 2015
XBI stock yearly return 2016
XBI stock yearly return 2017
XBI stock yearly return 2018
XBI stock yearly return 2019
XBI stock yearly return 2020
XBI stock yearly return 2021
XBI YTD return
 

XBI Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2022, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.